Variant report
| Variant | esv3380723 |
|---|---|
| Chromosome Location | chr5:180041148-180041324 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
| No data |
| No data |
| No data |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| FLT4 | TF binding region |
Variant overlapped rSNPs/rCNVs (count:28 , 50 per page) page:
1
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs535681122 | chr5:180041167-180041168 | Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs142705185 | chr5:180041174-180041175 | Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 3 | rs374885874 | chr5:180041177-180041178 | Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 4 | rs369575233 | chr5:180041189-180041190 | Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 5 | rs2934602 | chr5:180041190-180041191 | Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 6 | rs201584222 | chr5:180041193-180041194 | Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 7 | rs2934601 | chr5:180041200-180041201 | Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 8 | rs373004354 | chr5:180041206-180041207 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 9 | rs368887610 | chr5:180041207-180041208 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 10 | rs659268 | chr5:180041208-180041209 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 11 | rs375866221 | chr5:180041223-180041224 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 12 | rs55826717 | chr5:180041229-180041230 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 13 | rs545789156 | chr5:180041234-180041235 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 14 | rs556312299 | chr5:180041240-180041241 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 15 | rs55713910 | chr5:180041241-180041242 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 16 | rs2934600 | chr5:180041242-180041243 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 17 | rs144374310 | chr5:180041243-180041244 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 18 | rs576049956 | chr5:180041252-180041253 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 19 | rs113669125 | chr5:180041258-180041259 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 20 | rs58248706 | chr5:180041273-180041274 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 21 | rs2927582 | chr5:180041274-180041275 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 22 | rs57233361 | chr5:180041275-180041276 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 23 | rs13188530 | chr5:180041276-180041277 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 24 | rs188318248 | chr5:180041291-180041292 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 25 | rs527477555 | chr5:180041308-180041309 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 26 | rs541343108 | chr5:180041309-180041310 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 27 | rs7700544 | chr5:180041310-180041311 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 28 | rs56328898 | chr5:180041316-180041317 | Weak transcription Strong transcription Genic enhancers Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Gastrointestinal stromal cancer | 16982739 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Phyllodes tumor | 17334353 | CNVD |
| Malaria | 21533027 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Cancer | 20164919 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Cancer | 16751803 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Glioma | 20126413 | CNVD |
| Cancer | 22429812 | CNVD |
| Cancer | 21637783 | CNVD |
| Colorectal cancer | 20709793 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Acute lymphoblastic leukemia | 21390130 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Leukemia | 17361228 | CNVD |
| Myelodysplastic syndrome | 18508791 | CNVD |
| 5q-syndrome | 17576883 | CNVD |
| Gastric cancer | 17908304 | CNVD |
| Lung cancer | 16740712 | CNVD |
| Oral squamous cell carcinoma | 17134496 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Esophageal adenocarcinoma | 19417022 | CNVD |
| Barrett''s syndrome | 19417022 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| Salivary gland tumor | 18059337 | CNVD |
| Renal cell carcinoma | 19377443 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Gastrointestinal stromal cancer | 19259404 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Breast cancer | 20668451 | CNVD |
| Cancer | 20668451 | CNVD |
| Lung cancer | 20668451 | CNVD |
| Ovarian cancer | 20668451 | CNVD |
| Pancreas cancer | 20668451 | CNVD |
| Prostate cancer | 20668451 | CNVD |
| Myofibroblastic sarcoma | 19369631 | CNVD |
| Embryonal rhabdomyosarcoma | 16790082 | CNVD |
| Biliary cancer | 20360734 | CNVD |
| Breast cancer | 20360734 | CNVD |
| Coronary artery disease | 20360734 | CNVD |
| Crohn''s disease | 20360734 | CNVD |
| Hypertension | 20360734 | CNVD |
| Rheumatoid arthritis | 20360734 | CNVD |
| Type 1 diabetes | 20360734 | CNVD |
| Type 2 diabetes | 20360734 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| epilepsy | 18472482 | CNVD |
| Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
| Sotos syndrome | 21572526 | CNVD |
| T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
| Sotos syndrome | 17561922 | CNVD |
| Sotos syndrome | 16773131 | CNVD |
| Mental retardation | 16773131 | CNVD |
| Sotos syndrome | 22470819 | CNVD |
| Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
| Acute myeloid leukemia | 18000384 | CNVD |
| Sudden cardiac death | 19188705 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Chordoma | 18071362 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Olfactory neuroblastoma | 18408657 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| abnormal development | 18461090 | CNVD |
| T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
| Lung cancer | 17297452 | CNVD |
| Cancer | 20164920 | CNVD |
| Breast cancer | 21509527 | CNVD |
| Breast cancer | 21804112 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Sotos syndrome | 22283845 | CNVD |
| Breast cancer | 16272173 | CNVD |
| Sotos syndrome | 20503325 | CNVD |
| Lung adenocarcinoma | 17086460 | CNVD |
| Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Breast cancer | 19181860 | CNVD |
| Acute lymphoblastic leukemia | 21098271 | CNVD |
| Ehlers-danlos syndrome | 17576883 | CNVD |
| Lung cancer | 17086460 | CNVD |
| Autism | 19246517 | CNVD |
| Basal cell lymphoma | 19029149 | CNVD |
| Diffuse large b-cell lymphoma | 19029149 | CNVD |
| Autism | 22543975 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr5:180018800-180045800 | Weak transcription | Right Atrium | heart |
| 2 | chr5:180029400-180045600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
| 3 | chr5:180029800-180043200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
| 4 | chr5:180035600-180043400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
| 5 | chr5:180037200-180043200 | Weak transcription | Adipose Nuclei | Adipose |
| 6 | chr5:180037400-180043400 | Weak transcription | Right Ventricle | heart |
| 7 | chr5:180039200-180041400 | Strong transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
| 8 | chr5:180039600-180044000 | Strong transcription | ES-UCSF4 Cell Line | embryonic stem cell |
| 9 | chr5:180039800-180041400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
| 10 | chr5:180040000-180061200 | Weak transcription | Gastric | stomach |
| 11 | chr5:180040600-180041200 | Bivalent Enhancer | Placenta | Placenta |
| 12 | chr5:180040800-180041400 | Genic enhancers | Spleen | Spleen |
| 13 | chr5:180041000-180041200 | ZNF genes & repeats | Lung | lung |
| 14 | chr5:180041000-180041400 | Enhancers | HUVEC | blood vessel |
| 15 | chr5:180041200-180041600 | Weak transcription | Lung | lung |
| 16 | chr5:180041200-180041800 | Weak transcription | Placenta | Placenta |





